853-871
Review Article
Inhaled corticosteroids as combination therapy with β-adrenergic agonists in airways disease: present and future
Kian Fan Chung, Gaetano Caramori and Ian M. Adcock
873-880
Review Article
Children’s presence in research. A review of online registers
C. Pandolfini and M. Bonati
881-885
Clinical Trial
Co-administration of grapefruit juice increases bioavailability of tacrolimus in liver transplant patients: a prospective study
Chang Liu, Ya-Fei Shang, Xu-Feng Zhang, Xiao-Gang Zhang and Bo Wang, et al.
887-894
Pharmacogenetics
Impact of CYP2C19 phenotypes on escitalopram metabolism and an evaluation of pupillometry as a serotonergic biomarker
L. Noehr-Jensen, S. T. Zwisler, F. Larsen, S. H. Sindrup and P. Damkier, et al.
895-902
Pharmacogenetics
Polymorphisms and haplotype analysis of IL-4Rα Q576R and I75V in patients with penicillin allergy
Chen-Zheng Huang, Jing Yang, Hai-Ling Qiao and Lin-Jing Jia
903-911
Pharmacokinetics and Disposition
Exposure equivalence between IV (0.8 mg/kg) and oral (1 mg/kg) busulfan in adult patients
F. Léger, L. Nguyen and C. Puozzo
913-917
Pharmacokinetics and Disposition
Pharmacokinetics of ritodrine diastereomers in patients pregnant with singletons and twins
A. Konda, T. Ito, H. Yoshida, T. Toda and T. Hayakawa, et al.
919-925
Pharmacoepidemiology and Prescription
Open AccessUnintended consequences of reducing QT-alert overload in a computerized physician order entry system
Heleen van der Sijs, Ravi Kowlesar, Jos Aarts, Marc Berg and Arnold Vulto, et al.
927-933
Pharmacoepidemiology and Prescription
Selective prescribing of simvastatin and atorvastatin by patient characteristics at treatment initiation over a 7-year period in Finland
Heli Halava, Arja Helin-Salmivaara, Jouni Junnila and Risto Huupponen
935-940
Pharmacoeconomics
The National Poison Center in Norway: user satisfaction and a health economic evaluation
Else-Lydia Toverud, Eva Pike and Lars Walløe
941-946
Short Communication
Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET
Martin Bauer, Rudolf Karch, Friederike Neumann, Aiman Abrahim and Claudia C. Wagner, et al.
947-953
Short Communication
CYP2C9 genotype and pharmacodynamic responses to losartan in patients with primary and secondary kidney diseases
Melanie S. Joy, Kimberly Dornbrook-Lavender, Joyce Blaisdell, Tandrea Hilliard and Tammy Boyette, et al.
955-956
Letter to the Editors
Long-term retention rate of pramipexole in the treatment of Parkinson’s disease
Tapani Keränen, Mervi Tuhkasaari and Hanna Kuusisto
957
Letter to the Editors
Open AccessReply: long-term retention rate of pramipexole in the treatment of Parkinson’s disease
Maurits E. L. Arbouw, Kris L. L. Movig, Jeroen P. P. van Vugt and Toine C. G. Egberts